Related Experiment Video
Updated: Jul 14, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
[Pulmonary hypertension associated with refractory hyperthyroidism: a case report]
1Division of Cardiology, Fuchu Hospital, Hiko-cho 1-10-17, Izumi, Osaka 594-0076.
Graves' disease can cause reversible pulmonary hypertension. Thyroidectomy improved cardiac output and pulmonary hypertension, but not pulmonary vascular resistance, suggesting complex underlying mechanisms.
Area of Science:
- Cardiology
- Endocrinology
Background:
- Graves' disease, an autoimmune disorder, can lead to hyperthyroidism.
- Hyperthyroidism can cause significant cardiovascular complications, including pulmonary hypertension.
Observation:
- A 25-year-old woman with Graves' disease presented with goiter and echocardiographic findings of a hyperdynamic heart, right ventricular dilation, and tricuspid regurgitation.
- Right heart catheterization revealed high cardiac output and pulmonary hypertension with elevated pulmonary vascular resistance.
Findings:
- Subtotal thyroidectomy led to improvement in pulmonary hypertension and normalization of cardiac output.
- Pulmonary vascular resistance and total pulmonary resistance did not normalize post-surgery.
- Reversible pulmonary hypertension in hyperthyroidism may be linked to increased pulmonary blood flow and sustained pulmonary artery resistance, potentially involving pulmonary endothelial dysfunction.
Implications:
- Thyroidectomy can be an effective treatment for resolving pulmonary hypertension associated with Graves' disease.
- Persistent pulmonary vascular resistance suggests that long-term pulmonary vascular changes may occur despite successful thyroid treatment.
- Further research is needed to elucidate the mechanisms of pulmonary endothelial dysfunction in hyperthyroid-induced pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology

